SPROTT PHYSICAL URANIUM TR (U-U.CA)

CA85210A1049

16.84  -0.86 (-4.86%)

Fundamental Rating

5

Taking everything into account, U-U scores 5 out of 10 in our fundamental rating. U-U was compared to 79 industry peers in the Capital Markets industry. Both the health and profitability get an excellent rating, making U-U a very profitable company, without any liquidiy or solvency issues. U-U does not seem to be growing, but still is valued expensively.



7

1. Profitability

1.1 Basic Checks

In the past year U-U was profitable.
U-U had a negative operating cash flow in the past year.
U-U had positive earnings in 4 of the past 5 years.
U-U had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

U-U's Return On Assets of 45.42% is amongst the best of the industry. U-U outperforms 98.70% of its industry peers.
The Return On Equity of U-U (45.57%) is better than 97.40% of its industry peers.
Looking at the Return On Invested Capital, with a value of 32.81%, U-U belongs to the top of the industry, outperforming 97.40% of the companies in the same industry.
U-U had an Average Return On Invested Capital over the past 3 years of 13.96%. This is significantly above the industry average of 8.85%.
The last Return On Invested Capital (32.81%) for U-U is above the 3 year average (13.96%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 45.42%
ROE 45.57%
ROIC 32.81%
ROA(3y)19.31%
ROA(5y)14.82%
ROE(3y)19.38%
ROE(5y)14.86%
ROIC(3y)13.96%
ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 98.90%, U-U belongs to the best of the industry, outperforming 97.40% of the companies in the same industry.
In the last couple of years the Profit Margin of U-U has declined.
Looking at the Operating Margin, with a value of 98.90%, U-U belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of U-U has declined.
The Gross Margin of U-U (99.91%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of U-U has remained more or less at the same level.
Industry RankSector Rank
OM 98.9%
PM (TTM) 98.9%
GM 99.91%
OM growth 3Y-4.06%
OM growth 5Y-3.07%
PM growth 3Y-3.98%
PM growth 5Y-2.54%
GM growth 3Y-1.44%
GM growth 5Y-1.08%

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, U-U has more shares outstanding
The number of shares outstanding for U-U has been increased compared to 5 years ago.
U-U has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 112.10 indicates that U-U is not in any danger for bankruptcy at the moment.
The Altman-Z score of U-U (112.10) is better than 97.40% of its industry peers.
U-U has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 112.1
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 2.03 indicates that U-U has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.03, U-U is doing good in the industry, outperforming 64.94% of the companies in the same industry.
A Quick Ratio of 2.03 indicates that U-U has no problem at all paying its short term obligations.
The Quick ratio of U-U (2.03) is better than 64.94% of its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 2.03

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1153.88% over the past year.
U-U shows a strong growth in Revenue. In the last year, the Revenue has grown by 1140.80%.
EPS 1Y (TTM)1153.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1601.29%
Revenue 1Y (TTM)1140.8%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1880.46%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 1.18, which indicates a rather cheap valuation of U-U.
Based on the Price/Earnings ratio, U-U is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of U-U to the average of the S&P500 Index (29.62), we can say U-U is valued rather cheaply.
Industry RankSector Rank
PE 1.18
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The decent profitability rating of U-U may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

U-U does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SPROTT PHYSICAL URANIUM TR

TSX:U-U (9/6/2024, 7:00:00 PM)

16.84

-0.86 (-4.86%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.49B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 1.18
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 45.42%
ROE 45.57%
ROCE
ROIC
ROICexc
ROICexgc
OM 98.9%
PM (TTM) 98.9%
GM 99.91%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.03
Quick Ratio 2.03
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)1153.88%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1140.8%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y